Regeneron Pharmaceuticals Inc (REGN)

Current ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total current assets	US$ in thousands	19,479,200	15,884,100	14,014,900	9,779,100	7,689,100
Total current liabilities	US$ in thousands	3,423,400	3,141,300	3,932,500	2,697,400	2,096,600
Current ratio		5.69	5.06	3.56	3.63	3.67

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $19,479,200K ÷ $3,423,400K
= 5.69

The current ratio of Regeneron Pharmaceuticals, Inc. has exhibited a positive trend over the past five years, indicating a strengthening liquidity position. As of December 31, 2023, the company's current ratio stands at 5.69, which signifies that for every dollar of its current liabilities, Regeneron Pharmaceuticals has $5.69 in current assets available to cover those obligations in the short term.

Comparing this ratio to the previous years, there has been a consistent improvement in liquidity since 2021 when the current ratio was 3.56. The upward trend suggests that the company has been effectively managing its current assets and liabilities, ensuring that it has sufficient resources to meet its short-term financial obligations.

A current ratio above 1 indicates that the company has more current assets than current liabilities, which is considered a positive sign of financial health. Regeneron Pharmaceuticals' current ratio well above 1 and increasing trend over the years indicate a strong liquidity position, potentially enabling the company to fund its operations, investments, and growth initiatives without relying heavily on external financing.

Overall, the current ratio analysis suggests that Regeneron Pharmaceuticals, Inc. has a robust liquidity position and is well-positioned to meet its short-term financial obligations.